Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wuxi PharmaTech Obtains Humane Animal Treatment Accreditation For Toxicology Facility In Eastern China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - The leadership of Wuxi PharmaTech, China's dominant contract research organization, said the Shanghai-based outfit is on track to begin offering GLP-compliant drug safety testing services by the second half of the year at its new, leading-edge toxicology center

You may also be interested in...



Charles River-WuXi PharmaTech Deal Transforms China's CRO Landscape

Charles River's acquisition of WuXi PharmaTech, valued at $1.6 billion, is the largest merger so far in China's healthcare space and is likely to drastically change the CRO playing field in China

Charles River-WuXi PharmaTech Deal Transforms China's CRO Landscape

Charles River's acquisition of WuXi PharmaTech, valued at $1.6 billion, is the largest merger so far in China's healthcare space and is likely to drastically change the CRO playing field in China

China's Wuxi PharmaTech Signs New Agreement On Toxicology Studies Training And Services With J&J Unit

BEIJING - Just days after disclosing that a newly launched drug safety testing center had been accredited by a U.S. group, leading Chinese contract research organization Wuxi PharmaTech signed a toxicology deal with Johnson & Johnson Pharmaceutical Research & Development

Latest News
See All
UsernamePublicRestriction

Register

SC074219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel